The diagnosis of SLE is typically based on the established classification set by 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria [4], which incorporate both clinical and immunological features such as ANA positivity, complement levels, and disease-specific antibodies. This evidence concerns the gene BTG3 and systemic lupus erythematosus.